Literature DB >> 1888618

The effect of intra-arterial endothelin on resting blood flow and sympathetically mediated vasoconstriction in the forearm of man.

J R Cockcroft1, J G Clarke, D J Webb.   

Abstract

1. The hypothesis that endothelin (ET) influences sympathetically mediated vasoconstriction was investigated in 13 healthy, male subjects. 2. ET (1 pmol min-1) was infused for 60 min into the left brachial arteries of seven healthy male subjects. Resting forearm blood flow, and sympathetic vasoconstriction produced by lower body negative pressure (LBNP; 15 mm Hg), was measured in both arms by strain gauge plethysmography. In a further six subjects, noradrenaline (NA) was infused intra-arterially at doses of 150-600 pmol min-1, with and without co-infusion of ET (1 pmol min-1), with blood flow measured in both forearms. 3. ET produced a small but significant reduction of blood flow in the infused forearm from 3.9 +/- 0.6 ml 100 ml-1 min-1 during infusion of saline, to 3.3 +/- 0.7 ml 100 ml-1 min-1 during infusion of ET at 60 min (P less than 0.05). Blood flow in the non-infused forearm was not altered by ET infusion. 4. NA produced a significant and dose-dependent reduction of blood flow in the infused forearm from 3.13 +/- 0.5 ml 100 ml-1 min-1 during saline infusion, to 1.49 +/- 0.2 ml 100 ml-1 min-1 with NA at 600 pmol min-1 (P less than 0.001). During co-infusion of ET, blood flow was reduced similarly in the infused arm from 3.15 +/- 0.7 ml 100 ml-1 min-1 during saline infusion to 1.55 +/- 0.2 ml 100 ml-1 min-1 with NA at 600 pmol min-1. Blood flow in the non-infused arm was not altered by ET and NA infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888618      PMCID: PMC1368469          DOI: 10.1111/j.1365-2125.1991.tb05573.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  Circulatory responses of supine subjects to the exposure of parts of the body below the xiphisternum to subatmospheric pressure.

Authors:  B L Ardill; R G Bannister; P H Fentem; A D Greenfield
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

2.  Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteries.

Authors:  Y Tabuchi; M Nakamaru; H Rakugi; M Nagano; T Ogihara
Journal:  Biochem Biophys Res Commun       Date:  1989-03-31       Impact factor: 3.575

3.  Inhibition of adrenergic neuroeffector transmission by endothelin in the guinea-pig femoral artery.

Authors:  N P Wiklund; A Ohlén; B Cederqvist
Journal:  Acta Physiol Scand       Date:  1988-10

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Carotid and cardiopulmonary baroreceptor control of splanchnic and forearm vascular resistance during venous pooling in man.

Authors:  F M Abboud; D L Eckberg; U J Johannsen; A L Mark
Journal:  J Physiol       Date:  1979-01       Impact factor: 5.182

6.  Human vascular responses to endothelin-1: observations in vivo and in vitro.

Authors:  A D Hughes; S A Thom; N Woodall; M Schachter; W M Hair; G N Martin; P S Sever
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

7.  Characterization of endothelin-1 stimulation of catecholamine release from adrenal chromaffin cells.

Authors:  M R Boarder; D B Marriott
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

8.  Effect of endothelin-1 in man.

Authors:  H Vierhapper; O Wagner; P Nowotny; W Waldhäusl
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

9.  Sympathetically mediated vasoconstriction is augmented by angiotensin II in man.

Authors:  D J Webb; P H Seidelin; N Benjamin; J G Collier; A D Struthers
Journal:  J Hypertens Suppl       Date:  1988-12

10.  Endothelin is a potent long-lasting vasoconstrictor in men.

Authors:  J G Clarke; N Benjamin; S W Larkin; D J Webb; G J Davies; A Maseri
Journal:  Am J Physiol       Date:  1989-12
View more
  4 in total

1.  Characterization of the binding of endothelin ETB selective ligands in human and rat heart.

Authors:  F D Russell; A P Davenport
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Vascular function and endothelin-1: tipping the balance between vasodilation and vasoconstriction.

Authors:  Steven K Nishiyama; Jia Zhao; D Walter Wray; Russell S Richardson
Journal:  J Appl Physiol (1985)       Date:  2016-12-01

3.  Direct and sympathetically mediated venoconstriction in essential hypertension. Enhanced responses to endothelin-1.

Authors:  W G Haynes; M F Hand; H A Johnstone; P L Padfield; D J Webb
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  An investigation into the direct and indirect venoconstrictor effects of endothelin-1 and big endothelin-1 in man.

Authors:  W G Haynes; S Moffat; D J Webb
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.